The listing beat expectations as signalled by the grey market premium (GMP). Ahead of its debut today, Molbio Diagnostics IPO GMP was ₹120, suggesting 15 per cent listing pop.
Source: Business Standard
Solid debut! Molbio Diagnostics shares list at 21% premium over IPO price
Temp User
Listen to News
Click play to hear this story
